Lataa...
Who gets genomic testing for breast cancer recurrence risk?
BACKGROUND/AIMS: Our study examined whether patient characteristics, beliefs, and decision-making styles were associated with uptake of genomic testing for breast cancer recurrence risk. METHODS: Participants were 132 early-stage breast cancer patients eligible for the Oncotype DX genomic test. We i...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3884690/ https://ncbi.nlm.nih.gov/pubmed/23899493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000353518 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|